Kevin David Costa
Corporate Officer/Principal bei Icahn School of Medicine at Mount Sinai
Aktive Positionen von Kevin David Costa
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | 01.01.2009 | - |
Karriereverlauf von Kevin David Costa
Ehemalige bekannte Positionen von Kevin David Costa
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - | - |
| NOVOHEART HOLDINGS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | - |
| Gründer | 28.04.1964 | - |
Ausbildung von Kevin David Costa
| Boston University | Graduate Degree |
| University of California San Diego | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Novoheart Holdings, Inc.
 Novoheart Holdings, Inc. BiotechnologyHealth Technology Novoheart Holdings, Inc. is a global stem cell biotechnology company. It engages in engineering prototypes of bio-artificial human heart tissues and chambers for drug discovery, cardio toxicity screening, diseases modeling and therapeutic applications. The firm products include Human Ventricular Cardiomyocytes (hvCM), Cardiac Anisotropic Sheet (hvCAS), Cardiac Anisotropic Patch (hvCAP), Cardiac Tissue Strip (hvCTS), and novoHeart. The company was founded by Michelle Khine, Kevin Costa and Ronald Li on April 28, 1964 and is headquartered in Vancouver, Canada. | Health Technology |
- Börse
- Insiders
- Kevin David Costa
- Erfahrung
